Form 4: Mural Oncology's Chief Medical Officer Sells Shares to Cover Tax Obligations

Vicki L Goodman, Chief Medical Officer of Mural Oncology plc, sold 5,069 ordinary shares to satisfy withholding obligations related to vesting restricted stock units.

Summary

• On November 7, 2024, Vicki L Goodman, the Chief Medical Officer of Mural Oncology plc, sold 5,069 ordinary shares of the company.
• The sale was executed to cover withholding obligations associated with the vesting of restricted stock units granted on December 14, 2023.
• The shares were sold at a weighted average price of $3.33, with individual transactions ranging from $3.33 to $3.35.
• Following the transaction, Goodman beneficially owns 67,949 ordinary shares, including 54,763 unvested restricted stock units.
• The sale was conducted under a pre-arranged plan (Rule 10b5-1) established on December 21, 2023, to cover tax obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction appears to be a routine sale to cover tax obligations, executed under a pre-arranged plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating it was planned and not based on current market conditions or insider information.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders, as it is a relatively small transaction by an executive to cover tax obligations.

Key Dates